Results 101 to 110 of about 428 (116)
Some of the next articles are maybe not open access.
Clinical Experience with Afamelanotide for the Protoporphyrias in the United States
Blood, 2022Rebecca Karp Leaf +8 more
openaire +1 more source
A review and update on melanocyte stimulating hormone therapy: afamelanotide.
Journal of drugs in dermatology : JDD, 2014Afamelanotide ([Nle4-D-Phe7]-alpha-MSH) is an analog of alpha-melanocyte stimulating hormone given as a subcutaneous injection. Afamelanotide is currently undergoing phase II and III trials in Europe and the US for skin diseases including vitiligo, erythropoietic protoporphyria, polymorphic light eruption and prevention of actinic keratoses in organ ...
Jordan, Fabrikant +2 more
openaire +1 more source